Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-23-008697
Filing Date
2023-10-05
Accepted
2023-10-04 21:42:42
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2089596
2 GRAPHIC g530411g01a26.jpg GRAPHIC 55411
3 GRAPHIC g530411g01b26.jpg GRAPHIC 56528
4 GRAPHIC g530411g06p06.jpg GRAPHIC 108469
5 GRAPHIC g530411g07f07.jpg GRAPHIC 131677
6 GRAPHIC g530411g08p08.jpg GRAPHIC 133516
7 GRAPHIC g530411g11g01.jpg GRAPHIC 54510
8 GRAPHIC g530411g11g02.jpg GRAPHIC 50120
9 GRAPHIC g530411g12b01.jpg GRAPHIC 50220
10 GRAPHIC g530411g12b02.jpg GRAPHIC 91517
11 GRAPHIC g530411g13a00.jpg GRAPHIC 82579
12 GRAPHIC g530411g14a01.jpg GRAPHIC 144685
13 GRAPHIC g530411g14b02.jpg GRAPHIC 63744
14 GRAPHIC g530411g17g01.jpg GRAPHIC 120880
15 GRAPHIC g530411g19g01.jpg GRAPHIC 55292
16 GRAPHIC g530411g20g01.jpg GRAPHIC 171935
17 GRAPHIC g530411g21l01.jpg GRAPHIC 115718
  Complete submission text file 0000950123-23-008697.txt   4075271
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06910 | Film No.: 231309719
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)